YD Bio

About YD Bio

YD Bio is a biotechnology company advancing transformative biomedicine with a focus on early cancer detection, regenerative medicine, and clinical innovation. The company develops non-invasive dna methylation analysis for earlier cancer detection and monitoring, exosome-based therapies for ocular and regenerative applications, and ophthalmic products for dry eye care, alongside clinical trial drugs and supplements. Headquartered in the United States, the organization collaborates globally to accelerate science and bring precision health solutions to patients.